Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380883379> ?p ?o ?g. }
- W4380883379 abstract "Abstract Background Accurate, timely diagnosis of neuropsychiatric symptoms, in particular distinguishing primary psychiatric from neurological disorders and in younger people, can be challenging. Neurofilament light (NfL) and other blood biomarkers have shown promise to reduce the diagnostic odyssey and improve outcomes. The MiND Study in investigating the diagnostic utility of NfL and other markers, to distinguish neurological/neurodegenerative from psychiatric disorders, to lead to a widely available, routine screening blood test. Methods We assessed NfL, p‐tau181 and GFAP in broad cohorts, including: patients assessed for neurocognitive/psychiatric symptoms at Neuropsychiatry and other services, in a wide range of disorders including Alzheimer disease, frontotemporal dementia, schizophrenia, bipolar disorder, depression, functional neurological disorders, Niemann‐Pick Type C, epilepsy. Results Updates on the The MiND Study progress and findings that NfL differentiated diverse neurodegenerative from psychiatric disorders, with 90+% accuracy, from over 500 patients/participants, will be presented, with real patient and family stories to demonstrate the challenges and potential clinical impact of The MiND Study. Plasma P‐tau181 levels distinguished Alzheimer disease (mainly younger sporadic), from non‐Alzheimer. As recruitment, sample analysis, data collection is ongoing, the most up to date results including GFAP, cognitive and neuroimaging markers, will be presented. Conclusions NfL shows great promise as a diagnostic screening blood test, akin to a “CRP for the brain”. Plasma p‐tau181 shows strong diagnostic utility in younger‐onset Alzheimer disease. NfL could dramatically alter clinical care of patients with neuropsychiatric and neurological symptoms, improving outcomes for patients, their families, the healthcare system, and clinical trials, facilitating precision medicine algorithmic diagnostics incorporating other biomarkers and clinical/cognitive markers, for real‐world clinical settings." @default.
- W4380883379 created "2023-06-17" @default.
- W4380883379 creator A5005681347 @default.
- W4380883379 creator A5009397339 @default.
- W4380883379 creator A5010245045 @default.
- W4380883379 creator A5013169110 @default.
- W4380883379 creator A5018605276 @default.
- W4380883379 creator A5020077464 @default.
- W4380883379 creator A5021673373 @default.
- W4380883379 creator A5023451391 @default.
- W4380883379 creator A5025969837 @default.
- W4380883379 creator A5027333874 @default.
- W4380883379 creator A5030118440 @default.
- W4380883379 creator A5030389436 @default.
- W4380883379 creator A5036731916 @default.
- W4380883379 creator A5038776015 @default.
- W4380883379 creator A5041029206 @default.
- W4380883379 creator A5044860561 @default.
- W4380883379 creator A5047385288 @default.
- W4380883379 creator A5056083778 @default.
- W4380883379 creator A5059033472 @default.
- W4380883379 creator A5059823463 @default.
- W4380883379 creator A5060837113 @default.
- W4380883379 creator A5068394264 @default.
- W4380883379 creator A5077268112 @default.
- W4380883379 creator A5080587847 @default.
- W4380883379 creator A5081967097 @default.
- W4380883379 creator A5083219599 @default.
- W4380883379 creator A5084459021 @default.
- W4380883379 creator A5072894512 @default.
- W4380883379 date "2023-06-01" @default.
- W4380883379 modified "2023-09-27" @default.
- W4380883379 title "The Markers in Neuropsychiatric Disorders Study (The MiND Study): moving neurofilament light and other markers into the clinic to improve care for people with symptoms and illnesses of the mind and brain" @default.
- W4380883379 doi "https://doi.org/10.1002/alz.062655" @default.
- W4380883379 hasPublicationYear "2023" @default.
- W4380883379 type Work @default.
- W4380883379 citedByCount "0" @default.
- W4380883379 crossrefType "journal-article" @default.
- W4380883379 hasAuthorship W4380883379A5005681347 @default.
- W4380883379 hasAuthorship W4380883379A5009397339 @default.
- W4380883379 hasAuthorship W4380883379A5010245045 @default.
- W4380883379 hasAuthorship W4380883379A5013169110 @default.
- W4380883379 hasAuthorship W4380883379A5018605276 @default.
- W4380883379 hasAuthorship W4380883379A5020077464 @default.
- W4380883379 hasAuthorship W4380883379A5021673373 @default.
- W4380883379 hasAuthorship W4380883379A5023451391 @default.
- W4380883379 hasAuthorship W4380883379A5025969837 @default.
- W4380883379 hasAuthorship W4380883379A5027333874 @default.
- W4380883379 hasAuthorship W4380883379A5030118440 @default.
- W4380883379 hasAuthorship W4380883379A5030389436 @default.
- W4380883379 hasAuthorship W4380883379A5036731916 @default.
- W4380883379 hasAuthorship W4380883379A5038776015 @default.
- W4380883379 hasAuthorship W4380883379A5041029206 @default.
- W4380883379 hasAuthorship W4380883379A5044860561 @default.
- W4380883379 hasAuthorship W4380883379A5047385288 @default.
- W4380883379 hasAuthorship W4380883379A5056083778 @default.
- W4380883379 hasAuthorship W4380883379A5059033472 @default.
- W4380883379 hasAuthorship W4380883379A5059823463 @default.
- W4380883379 hasAuthorship W4380883379A5060837113 @default.
- W4380883379 hasAuthorship W4380883379A5068394264 @default.
- W4380883379 hasAuthorship W4380883379A5072894512 @default.
- W4380883379 hasAuthorship W4380883379A5077268112 @default.
- W4380883379 hasAuthorship W4380883379A5080587847 @default.
- W4380883379 hasAuthorship W4380883379A5081967097 @default.
- W4380883379 hasAuthorship W4380883379A5083219599 @default.
- W4380883379 hasAuthorship W4380883379A5084459021 @default.
- W4380883379 hasBestOaLocation W43808833791 @default.
- W4380883379 hasConcept C118552586 @default.
- W4380883379 hasConcept C126322002 @default.
- W4380883379 hasConcept C134011695 @default.
- W4380883379 hasConcept C139719470 @default.
- W4380883379 hasConcept C15744967 @default.
- W4380883379 hasConcept C162324750 @default.
- W4380883379 hasConcept C169900460 @default.
- W4380883379 hasConcept C172467417 @default.
- W4380883379 hasConcept C2776412080 @default.
- W4380883379 hasConcept C2776867660 @default.
- W4380883379 hasConcept C2779134260 @default.
- W4380883379 hasConcept C2779483572 @default.
- W4380883379 hasConcept C2779878486 @default.
- W4380883379 hasConcept C70410870 @default.
- W4380883379 hasConcept C71924100 @default.
- W4380883379 hasConceptScore W4380883379C118552586 @default.
- W4380883379 hasConceptScore W4380883379C126322002 @default.
- W4380883379 hasConceptScore W4380883379C134011695 @default.
- W4380883379 hasConceptScore W4380883379C139719470 @default.
- W4380883379 hasConceptScore W4380883379C15744967 @default.
- W4380883379 hasConceptScore W4380883379C162324750 @default.
- W4380883379 hasConceptScore W4380883379C169900460 @default.
- W4380883379 hasConceptScore W4380883379C172467417 @default.
- W4380883379 hasConceptScore W4380883379C2776412080 @default.
- W4380883379 hasConceptScore W4380883379C2776867660 @default.
- W4380883379 hasConceptScore W4380883379C2779134260 @default.
- W4380883379 hasConceptScore W4380883379C2779483572 @default.
- W4380883379 hasConceptScore W4380883379C2779878486 @default.
- W4380883379 hasConceptScore W4380883379C70410870 @default.
- W4380883379 hasConceptScore W4380883379C71924100 @default.
- W4380883379 hasIssue "S2" @default.
- W4380883379 hasLocation W43808833791 @default.
- W4380883379 hasOpenAccess W4380883379 @default.